Log in to save to my catalogue

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506028541

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

About this item

Full title

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2020-12

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Abstract The ongoing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic necessitates the fast development of vaccines to meet a worldwide need. mRNA-based vaccines are the most promising technology for rapid and safe SARS-CoV-2 vaccine development and production. We have designed CVnCoV, a lipid-nanoparticle (LNP) encapsulated, s...

Alternative Titles

Full title

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2506028541

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506028541

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2020.12.23.424138